Advertisement

Pediatric Radiology

, Volume 24, Issue 7, pp 513–515 | Cite as

Urine interleukin-6 and interleukin-8 in children with acute pyelonephritis, in relation to DMSA scintigraphy in the acute phase and at 1-year follow-up

  • K. Tullus
  • O. Fituri
  • T. Linné
  • R. Escobar-Billing
  • I. Wikstad
  • A. Karlsson
  • L. G. Burman
  • B. Wretlind
  • A. Brauner
Originals

Abstract

The relationship between urine interleukin-6 (IL-6) and interleukin-8 (IL-8)/creatinine quotients and99mTc-dimercaptosuccinic acid (DMSA) scintigraphy, performed within 10 days of acute first-time pyelonephritis and after 1 year, was studied in 41 children. The urine IL-6 and IL-8/creatinine quotients were also related to the urineN-acetyl-β-D-glucosaminidase (NAG) and albumin/creatinine quotients. Presence of DMSA uptake defects, reflecting local inflammation, in children in the acute phase of pyelonephritis, were associated with elevated urine IL-6/creatinine quotients (median 27 pg/μmol); in children without DMSA changes there was no increase in quotients (median non-detectable) (P<0.05). Persistent DMSA changes at the 1-year follow-up, probably reflecting renal scarring, were only seen in children with increased urine IL-6/creatinine quotients in the acute phase (P<0.01). No correlation was found between urine IL-8 and DMSA uptake defects. Vesicoureteral reflux (VUR) at 6–8 weeks did not correlate with the urine cytokine levels in the acute phase. The urine excretion of NAG and albumin, reflecting renal dysfunction, was associated with values of both urine IL-6 and IL-8/creatinine quotients, but not with DMSA defects or VUR. Thus, the initial urine IL-6/creatinine quotients might be used as an indicator of risk for persistent renal damage in acute pyelonephritis.

Keywords

Acute Phase Urine Excretion Cytokine Level Pyelonephritis Renal Damage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Verber IG, Meller ST (1989) Serial99mTc-dimercaptosuccinic acid (DMSA) scans after urinary infections presenting before the age of 5 years. Arch Dis Child 64: 1533–1537PubMedGoogle Scholar
  2. 2.
    Jacobsson B, Nolstedt L, Svensson L, Söderlundh S, Berg U (1992)99mTechnetium-dimercaptosuccinic acid scan in the diagnosis of acute pyelonephritis in children: relation to clinical and radiological findings. Pediatr Nephrol 6: 328–334PubMedGoogle Scholar
  3. 3.
    Shanon A, Feldman W, McDonald P, Martin DJ, Matzinger MA, Shillinger JF, McLaine PN, Wolfish N (1992) Evaluation of renal scars by technetium-labeled dimercaptosuccinic acid scan, intravenous urography, and ultrasonography: a comparative study. J Pediatr 120: 399–403PubMedGoogle Scholar
  4. 4.
    Parkhouse HF, Godley ML, Cooper J, Risdon RA, Ransley PG (1989) Renal imaging with99mTc-labelled DMSA in the detection of acute pyelonephritis: an experimental study in the pig. Nucl Med Commun 10: 63–70PubMedGoogle Scholar
  5. 5.
    Arnold AJ, Brownless SM, Carty HM, Rickwood AMK (1990) Detection of renal scarring by DMSA scanning-an experimental study. J Pediatr Surg 25: 391–393PubMedGoogle Scholar
  6. 6.
    Wikstad I, Hannerz L, Karlsson A, Eklöf A-C, Olling S, Aperia A (1990)99mTechnetium dimercaptosuccinic acid scintigraphy in the diagnosis of acute pyelonephritis in rats. Pediatr Nephrol 4: 331–334PubMedGoogle Scholar
  7. 7.
    Smellie JM, Shaw PJ, Prescod NP, Bantock HM (1988)99mTc-dimercaptosuccinic acid (DMSA) scans in patients with established radiological renal scarring. Arch Dis Child 63: 1315–1319PubMedGoogle Scholar
  8. 8.
    Whitear P, Shaw P, Gordon I (1990) Comparison of99mTc-dimercaptosuccinic acid scans and intravenous urography in children. Br J Radiol 63: 438–443PubMedGoogle Scholar
  9. 9.
    Linné T, Fituri O, Escobar-Billing R, Karlsson A, Wikstad I, Aperia A, Tullus K (1994)99mTc-dimercaptosuccinic acid scintigraphy and functional parameters in acute pyelonephritis. Pediatr Nephrol (in press)Google Scholar
  10. 10.
    Hedges S, Stenqvist K, Lidin-Janson G, Martinell J, Sandberg T, Svanborg C (1992) Comparison of urine and serum concentrations of interleukin-6 in women with acute pyelonephritis or asymptomatic bacteriuria. J Infect Dis 166: 653–656PubMedGoogle Scholar
  11. 11.
    Ohta K, Takano N, Seno A, Yachie A, Miyawaki T, Yokohama H, Tomosugi N, Kato E, Taniguchi N (1992) Detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and urinary tract. Clin Nephrol 38: 185–189PubMedGoogle Scholar
  12. 12.
    Ko Y-C, Mukaída N, Ishiyama S, Tokue A, Kawai T, Matsushima K, Kasahara T (1993) Elevated interleukin-8 levels in the urine of patients with urinary tract infection. Infect Immun 61: 1307–1314PubMedGoogle Scholar
  13. 13.
    Tullus K, Fituri O, Burman LG, Wretlind B, Brauner A (1994) Interleukin-6 and interleukin-8 in the urine of children with acute pyelonephritis. Pediatr Nephrol 8: 280–284PubMedGoogle Scholar
  14. 14.
    Snick van J (1990) Interleukin-6: an overview. Annu Rev Immunol 8: 253–278PubMedGoogle Scholar
  15. 15.
    Schröder JM (1992) Interleukin 8. Adv Neuroimmunol 2: 109–124Google Scholar
  16. 16.
    Jodal U, Lindberg U, Lincoln K (1975) Level diagnosis of symptomatic urinary tract infections in childhood. Acta Paediatr Scand 64: 201–208PubMedGoogle Scholar
  17. 17.
    International Reflux Study Committee Report (1981) Medical versus surgical treatment. A prospective international reflux study in children. J Urol 125: 277–283Google Scholar
  18. 18.
    Masson P, Ohlsson P, Björkhem I (1981) Combined enzymic-Jaffé method for determination of creatinine in serum. Clin Chem 27: 18–21PubMedGoogle Scholar
  19. 19.
    Sullivan JS, Kilpatrick L, Costarino Jr AT, Lee SC, Harris MC (1992) Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 120: 510–515PubMedGoogle Scholar
  20. 20.
    Mustafa MM, Ramilo O, Saez-Llorenz X, Olsen KD, Magness RR, McCracken Jr GH (1990) Cerebrospinal fluid prostaglandins, interleukin 1beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebotreated and dexamethasone-treated patients. Am J Dis Child 144: 883–887PubMedGoogle Scholar
  21. 21.
    Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DF, Hoyt MJ, Stewart SM, Kennert BD, Olsen KD, McCracken Jr GH (1988) Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med 319: 964–971PubMedGoogle Scholar
  22. 22.
    Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC (1990) Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348: 550–552PubMedGoogle Scholar
  23. 23.
    Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA (1991) A specific receptor antagonist for interleukin 1 preventsEscherichia coli-induced shock in rabbits. FASEB J 5: 338–343PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • K. Tullus
    • 1
  • O. Fituri
    • 1
  • T. Linné
    • 1
  • R. Escobar-Billing
    • 2
  • I. Wikstad
    • 2
  • A. Karlsson
    • 3
  • L. G. Burman
    • 4
  • B. Wretlind
    • 5
  • A. Brauner
    • 6
  1. 1.Department of PediatricsSt. Göran's Children's HospitalStockholmSweden
  2. 2.Department of Pediatric RadiologySt. Göran's Children's HospitalStockholmSweden
  3. 3.Department of Hospital PhysicsSt. Göran's HospitalStockholmSweden
  4. 4.Department of BacteriologySwedish Institute of Infectious Disease ControlStockholmSweden
  5. 5.Department of BacteriologyHuddinge HospitalHuddingeSweden
  6. 6.Department of BacteriologyKarolinska HospitalStockholmSweden

Personalised recommendations